Tenecteplase Injection for Stroke: The Critical 4.5-Hour Window

"Early Treatment, Better Life."

Tenecteplase is a modern therapeutic drug designed to dissolve blood clots obstructing brain arteries, restoring cerebral circulation and minimizing long-term brain injury.

When Is It Administered?

• Critical Window: Must be administered within 4.5 hours of symptom onset.
• Proven Efficacy: Clinically proven to be safe and effective in properly screened patients.

Key Benefits

• Single Injection: Fast and simple IV administration via a single dose.
• Dissolves Clots: Rapidly breaks down the clot blocking blood supply to brain tissue.
• Prevents Disability: Reduces brain damage, lowering the chance of long-term disability.
• Supports Recovery: Enhances the likelihood of returning to a normal, functional life.

Recognizing Stroke Symptoms (FAST)

• F (Face): Facial drooping on one side.
• A (Arm): Weakness or loss of strength in one arm.
• S (Speech): Slurred speech or difficulty articulating words.
• T (Time): Time is brain — reach an emergency hospital immediately.

Important Clinical Warnings

This injection is not suitable for every stroke case. It must only be administered by an expert medical practitioner after necessary scans and diagnostic evaluations.

References & Clinical Guidelines

1. The Lancet (AcT Trial): Menon, B. K., et al. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke: a randomised controlled trial.

2. European Stroke Organisation (ESO): Clinical Guidelines on Intravenous Thrombolysis for Acute Ischaemic Stroke.

3. American Heart Association / American Stroke Association (AHA/ASA): Guidelines for the Management of Acute Ischemic Stroke & FAST Warning Sign Protocol.